nodes	percent_of_prediction	percent_of_DWPC	metapath
Valproic Acid—HDAC2—melanoma	0.485	1	CbGaD
Valproic Acid—SLC22A5—Dactinomycin—melanoma	0.0583	0.254	CbGbCtD
Valproic Acid—SLC22A7—Docetaxel—melanoma	0.0403	0.175	CbGbCtD
Valproic Acid—CYP1A2—Carmustine—melanoma	0.0322	0.14	CbGbCtD
Valproic Acid—CYP1A2—Vemurafenib—melanoma	0.0255	0.111	CbGbCtD
Valproic Acid—CYP3A4—Temozolomide—melanoma	0.0243	0.106	CbGbCtD
Valproic Acid—CYP1A2—Dacarbazine—melanoma	0.0195	0.0849	CbGbCtD
Valproic Acid—CYP3A4—Vemurafenib—melanoma	0.0133	0.058	CbGbCtD
Valproic Acid—CYP3A5—Docetaxel—melanoma	0.0117	0.0511	CbGbCtD
Valproic Acid—CYP3A4—Docetaxel—melanoma	0.00458	0.0199	CbGbCtD
Valproic Acid—SLC22A8—optic choroid—melanoma	0.0019	0.0858	CbGeAlD
Valproic Acid—OGDH—eye—melanoma	0.00126	0.057	CbGeAlD
Valproic Acid—OGDH—retina—melanoma	0.00125	0.0565	CbGeAlD
Valproic Acid—HDAC2—hair follicle—melanoma	0.00114	0.0515	CbGeAlD
Valproic Acid—HDAC9—eye—melanoma	0.00111	0.0503	CbGeAlD
Valproic Acid—ACADSB—mammalian vulva—melanoma	0.000795	0.0359	CbGeAlD
Valproic Acid—UGT1A8—head—melanoma	0.00077	0.0348	CbGeAlD
Valproic Acid—HDAC2—neck—melanoma	0.000764	0.0346	CbGeAlD
Valproic Acid—ABAT—eye—melanoma	0.000754	0.0341	CbGeAlD
Valproic Acid—ABAT—retina—melanoma	0.000747	0.0338	CbGeAlD
Valproic Acid—OGDH—head—melanoma	0.000716	0.0324	CbGeAlD
Valproic Acid—HDAC9—head—melanoma	0.000631	0.0285	CbGeAlD
Valproic Acid—CYP2C18—mammalian vulva—melanoma	0.000597	0.027	CbGeAlD
Valproic Acid—HDAC2—eye—melanoma	0.000568	0.0257	CbGeAlD
Valproic Acid—HDAC2—retina—melanoma	0.000563	0.0255	CbGeAlD
Valproic Acid—SLC16A1—eye—melanoma	0.000505	0.0228	CbGeAlD
Valproic Acid—OGDH—lymph node—melanoma	0.000501	0.0227	CbGeAlD
Valproic Acid—ALDH5A1—head—melanoma	0.0005	0.0226	CbGeAlD
Valproic Acid—SLC16A1—retina—melanoma	0.0005	0.0226	CbGeAlD
Valproic Acid—HDAC2—skin of body—melanoma	0.000494	0.0224	CbGeAlD
Valproic Acid—PTGS1—endothelium—melanoma	0.000461	0.0209	CbGeAlD
Valproic Acid—HDAC9—lymph node—melanoma	0.000442	0.02	CbGeAlD
Valproic Acid—ABAT—head—melanoma	0.000428	0.0194	CbGeAlD
Valproic Acid—PTGS1—blood vessel—melanoma	0.000426	0.0193	CbGeAlD
Valproic Acid—ACADSB—lymph node—melanoma	0.000398	0.018	CbGeAlD
Valproic Acid—SLC22A8—eye—melanoma	0.000382	0.0173	CbGeAlD
Valproic Acid—ALDH5A1—lymph node—melanoma	0.00035	0.0159	CbGeAlD
Valproic Acid—HDAC2—head—melanoma	0.000322	0.0146	CbGeAlD
Valproic Acid—ABAT—lymph node—melanoma	0.0003	0.0136	CbGeAlD
Valproic Acid—SLC16A1—head—melanoma	0.000287	0.013	CbGeAlD
Valproic Acid—SLC22A5—retina—melanoma	0.000286	0.0129	CbGeAlD
Valproic Acid—SLC22A5—skin of body—melanoma	0.000251	0.0114	CbGeAlD
Valproic Acid—HDAC2—lymph node—melanoma	0.000226	0.0102	CbGeAlD
Valproic Acid—CYP2B6—skin of body—melanoma	0.000218	0.00986	CbGeAlD
Valproic Acid—SLC22A8—head—melanoma	0.000217	0.0098	CbGeAlD
Valproic Acid—SLC16A1—lymph node—melanoma	0.000201	0.00908	CbGeAlD
Valproic Acid—PTGS1—skin of body—melanoma	0.000197	0.00891	CbGeAlD
Valproic Acid—PTGS1—mammalian vulva—melanoma	0.00018	0.00813	CbGeAlD
Valproic Acid—Arrhythmia—Carmustine—melanoma	0.000178	0.00137	CcSEcCtD
Valproic Acid—Leukopenia—Bleomycin—melanoma	0.000178	0.00137	CcSEcCtD
Valproic Acid—Dizziness—Vemurafenib—melanoma	0.000177	0.00136	CcSEcCtD
Valproic Acid—Alopecia—Carmustine—melanoma	0.000176	0.00135	CcSEcCtD
Valproic Acid—Angiopathy—Temozolomide—melanoma	0.000175	0.00134	CcSEcCtD
Valproic Acid—Mental disorder—Carmustine—melanoma	0.000175	0.00134	CcSEcCtD
Valproic Acid—Ataxia—Docetaxel—melanoma	0.000174	0.00134	CcSEcCtD
Valproic Acid—Immune system disorder—Temozolomide—melanoma	0.000174	0.00134	CcSEcCtD
Valproic Acid—Mediastinal disorder—Temozolomide—melanoma	0.000174	0.00133	CcSEcCtD
Valproic Acid—Malnutrition—Carmustine—melanoma	0.000174	0.00133	CcSEcCtD
Valproic Acid—Cough—Bleomycin—melanoma	0.000173	0.00133	CcSEcCtD
Valproic Acid—Chills—Temozolomide—melanoma	0.000173	0.00133	CcSEcCtD
Valproic Acid—Ill-defined disorder—Dactinomycin—melanoma	0.000172	0.00132	CcSEcCtD
Valproic Acid—Anaemia—Dactinomycin—melanoma	0.000171	0.00132	CcSEcCtD
Valproic Acid—Vomiting—Vemurafenib—melanoma	0.00017	0.00131	CcSEcCtD
Valproic Acid—Alopecia—Temozolomide—melanoma	0.00017	0.00131	CcSEcCtD
Valproic Acid—Dry skin—Docetaxel—melanoma	0.00017	0.0013	CcSEcCtD
Valproic Acid—Chest pain—Bleomycin—melanoma	0.000169	0.0013	CcSEcCtD
Valproic Acid—Myalgia—Bleomycin—melanoma	0.000169	0.0013	CcSEcCtD
Valproic Acid—Orthostatic hypotension—Docetaxel—melanoma	0.000169	0.0013	CcSEcCtD
Valproic Acid—Abdominal pain upper—Docetaxel—melanoma	0.000169	0.0013	CcSEcCtD
Valproic Acid—Rash—Vemurafenib—melanoma	0.000169	0.0013	CcSEcCtD
Valproic Acid—Mental disorder—Temozolomide—melanoma	0.000169	0.0013	CcSEcCtD
Valproic Acid—Dermatitis—Vemurafenib—melanoma	0.000169	0.0013	CcSEcCtD
Valproic Acid—Back pain—Carmustine—melanoma	0.000168	0.00129	CcSEcCtD
Valproic Acid—Headache—Vemurafenib—melanoma	0.000168	0.00129	CcSEcCtD
Valproic Acid—Malnutrition—Temozolomide—melanoma	0.000168	0.00129	CcSEcCtD
Valproic Acid—Breast disorder—Docetaxel—melanoma	0.000167	0.00129	CcSEcCtD
Valproic Acid—Discomfort—Bleomycin—melanoma	0.000167	0.00129	CcSEcCtD
Valproic Acid—Malaise—Dactinomycin—melanoma	0.000167	0.00128	CcSEcCtD
Valproic Acid—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000167	0.00128	CcSEcCtD
Valproic Acid—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000167	0.00128	CcSEcCtD
Valproic Acid—Leukopenia—Dactinomycin—melanoma	0.000166	0.00128	CcSEcCtD
Valproic Acid—Dysgeusia—Temozolomide—melanoma	0.000164	0.00126	CcSEcCtD
Valproic Acid—Confusional state—Bleomycin—melanoma	0.000164	0.00126	CcSEcCtD
Valproic Acid—Vision blurred—Carmustine—melanoma	0.000164	0.00126	CcSEcCtD
Valproic Acid—Alanine aminotransferase increased—Docetaxel—melanoma	0.000163	0.00126	CcSEcCtD
Valproic Acid—Tremor—Carmustine—melanoma	0.000163	0.00125	CcSEcCtD
Valproic Acid—Oedema—Bleomycin—melanoma	0.000162	0.00125	CcSEcCtD
Valproic Acid—Anaphylactic shock—Bleomycin—melanoma	0.000162	0.00125	CcSEcCtD
Valproic Acid—Back pain—Temozolomide—melanoma	0.000162	0.00125	CcSEcCtD
Valproic Acid—Infection—Bleomycin—melanoma	0.000161	0.00124	CcSEcCtD
Valproic Acid—Anaemia—Carmustine—melanoma	0.00016	0.00123	CcSEcCtD
Valproic Acid—Dysphagia—Docetaxel—melanoma	0.00016	0.00123	CcSEcCtD
Valproic Acid—Agitation—Carmustine—melanoma	0.000159	0.00123	CcSEcCtD
Valproic Acid—Nausea—Vemurafenib—melanoma	0.000159	0.00122	CcSEcCtD
Valproic Acid—Thrombocytopenia—Bleomycin—melanoma	0.000159	0.00122	CcSEcCtD
Valproic Acid—Vision blurred—Temozolomide—melanoma	0.000158	0.00121	CcSEcCtD
Valproic Acid—Myalgia—Dactinomycin—melanoma	0.000158	0.00121	CcSEcCtD
Valproic Acid—Tremor—Temozolomide—melanoma	0.000157	0.00121	CcSEcCtD
Valproic Acid—Discomfort—Dactinomycin—melanoma	0.000156	0.0012	CcSEcCtD
Valproic Acid—Ill-defined disorder—Temozolomide—melanoma	0.000156	0.0012	CcSEcCtD
Valproic Acid—Leukopenia—Carmustine—melanoma	0.000155	0.00119	CcSEcCtD
Valproic Acid—Anaemia—Temozolomide—melanoma	0.000155	0.00119	CcSEcCtD
Valproic Acid—Anorexia—Bleomycin—melanoma	0.000155	0.00119	CcSEcCtD
Valproic Acid—Agitation—Temozolomide—melanoma	0.000154	0.00118	CcSEcCtD
Valproic Acid—Angioedema—Temozolomide—melanoma	0.000153	0.00118	CcSEcCtD
Valproic Acid—Pancytopenia—Docetaxel—melanoma	0.000152	0.00117	CcSEcCtD
Valproic Acid—Hypotension—Bleomycin—melanoma	0.000152	0.00117	CcSEcCtD
Valproic Acid—Oedema—Dactinomycin—melanoma	0.000151	0.00116	CcSEcCtD
Valproic Acid—Malaise—Temozolomide—melanoma	0.000151	0.00116	CcSEcCtD
Valproic Acid—Vertigo—Temozolomide—melanoma	0.000151	0.00116	CcSEcCtD
Valproic Acid—Infection—Dactinomycin—melanoma	0.00015	0.00116	CcSEcCtD
Valproic Acid—Leukopenia—Temozolomide—melanoma	0.00015	0.00115	CcSEcCtD
Valproic Acid—Hypertension—Carmustine—melanoma	0.00015	0.00115	CcSEcCtD
Valproic Acid—Neutropenia—Docetaxel—melanoma	0.00015	0.00115	CcSEcCtD
Valproic Acid—Palpitations—Temozolomide—melanoma	0.000148	0.00114	CcSEcCtD
Valproic Acid—Thrombocytopenia—Dactinomycin—melanoma	0.000148	0.00114	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Bleomycin—melanoma	0.000148	0.00114	CcSEcCtD
Valproic Acid—Myalgia—Carmustine—melanoma	0.000148	0.00114	CcSEcCtD
Valproic Acid—Chest pain—Carmustine—melanoma	0.000148	0.00114	CcSEcCtD
Valproic Acid—Anxiety—Carmustine—melanoma	0.000147	0.00113	CcSEcCtD
Valproic Acid—Cough—Temozolomide—melanoma	0.000146	0.00112	CcSEcCtD
Valproic Acid—Paraesthesia—Bleomycin—melanoma	0.000146	0.00112	CcSEcCtD
Valproic Acid—Weight increased—Docetaxel—melanoma	0.000146	0.00112	CcSEcCtD
Valproic Acid—Weight decreased—Docetaxel—melanoma	0.000145	0.00111	CcSEcCtD
Valproic Acid—Hypertension—Temozolomide—melanoma	0.000145	0.00111	CcSEcCtD
Valproic Acid—Dyspnoea—Bleomycin—melanoma	0.000145	0.00111	CcSEcCtD
Valproic Acid—Anorexia—Dactinomycin—melanoma	0.000144	0.00111	CcSEcCtD
Valproic Acid—Pneumonia—Docetaxel—melanoma	0.000144	0.0011	CcSEcCtD
Valproic Acid—Confusional state—Carmustine—melanoma	0.000143	0.0011	CcSEcCtD
Valproic Acid—Myalgia—Temozolomide—melanoma	0.000143	0.0011	CcSEcCtD
Valproic Acid—Arthralgia—Temozolomide—melanoma	0.000143	0.0011	CcSEcCtD
Valproic Acid—Anxiety—Temozolomide—melanoma	0.000142	0.00109	CcSEcCtD
Valproic Acid—CYP2B6—head—melanoma	0.000142	0.00643	CbGeAlD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000142	0.00109	CcSEcCtD
Valproic Acid—Oedema—Carmustine—melanoma	0.000142	0.00109	CcSEcCtD
Valproic Acid—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000141	0.00109	CcSEcCtD
Valproic Acid—Discomfort—Temozolomide—melanoma	0.000141	0.00108	CcSEcCtD
Valproic Acid—Decreased appetite—Bleomycin—melanoma	0.000141	0.00108	CcSEcCtD
Valproic Acid—Infection—Carmustine—melanoma	0.000141	0.00108	CcSEcCtD
Valproic Acid—Dry mouth—Temozolomide—melanoma	0.00014	0.00107	CcSEcCtD
Valproic Acid—Stomatitis—Docetaxel—melanoma	0.000139	0.00107	CcSEcCtD
Valproic Acid—Pain—Bleomycin—melanoma	0.000139	0.00107	CcSEcCtD
Valproic Acid—Conjunctivitis—Docetaxel—melanoma	0.000139	0.00107	CcSEcCtD
Valproic Acid—Thrombocytopenia—Carmustine—melanoma	0.000139	0.00107	CcSEcCtD
Valproic Acid—Tachycardia—Carmustine—melanoma	0.000138	0.00106	CcSEcCtD
Valproic Acid—Confusional state—Temozolomide—melanoma	0.000138	0.00106	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000138	0.00106	CcSEcCtD
Valproic Acid—Anaphylactic shock—Temozolomide—melanoma	0.000137	0.00105	CcSEcCtD
Valproic Acid—Oedema—Temozolomide—melanoma	0.000137	0.00105	CcSEcCtD
Valproic Acid—Infection—Temozolomide—melanoma	0.000136	0.00104	CcSEcCtD
Valproic Acid—Anorexia—Carmustine—melanoma	0.000135	0.00104	CcSEcCtD
Valproic Acid—Hepatobiliary disease—Docetaxel—melanoma	0.000135	0.00104	CcSEcCtD
Valproic Acid—Epistaxis—Docetaxel—melanoma	0.000135	0.00103	CcSEcCtD
Valproic Acid—Nervous system disorder—Temozolomide—melanoma	0.000134	0.00103	CcSEcCtD
Valproic Acid—Thrombocytopenia—Temozolomide—melanoma	0.000134	0.00103	CcSEcCtD
Valproic Acid—Feeling abnormal—Bleomycin—melanoma	0.000134	0.00103	CcSEcCtD
Valproic Acid—Agranulocytosis—Docetaxel—melanoma	0.000133	0.00102	CcSEcCtD
Valproic Acid—Skin disorder—Temozolomide—melanoma	0.000133	0.00102	CcSEcCtD
Valproic Acid—Hypotension—Carmustine—melanoma	0.000132	0.00102	CcSEcCtD
Valproic Acid—Hyperhidrosis—Temozolomide—melanoma	0.000132	0.00102	CcSEcCtD
Valproic Acid—Decreased appetite—Dactinomycin—melanoma	0.000132	0.00101	CcSEcCtD
Valproic Acid—Fatigue—Dactinomycin—melanoma	0.00013	0.001	CcSEcCtD
Valproic Acid—Anorexia—Temozolomide—melanoma	0.00013	0.001	CcSEcCtD
Valproic Acid—Pain—Dactinomycin—melanoma	0.000129	0.000994	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Carmustine—melanoma	0.000129	0.000992	CcSEcCtD
Valproic Acid—Urticaria—Bleomycin—melanoma	0.000129	0.000991	CcSEcCtD
Valproic Acid—Haemoglobin—Docetaxel—melanoma	0.000129	0.000989	CcSEcCtD
Valproic Acid—PTGS1—head—melanoma	0.000129	0.00582	CbGeAlD
Valproic Acid—Rhinitis—Docetaxel—melanoma	0.000128	0.000987	CcSEcCtD
Valproic Acid—Body temperature increased—Bleomycin—melanoma	0.000128	0.000986	CcSEcCtD
Valproic Acid—Haemorrhage—Docetaxel—melanoma	0.000128	0.000984	CcSEcCtD
Valproic Acid—Insomnia—Carmustine—melanoma	0.000128	0.000984	CcSEcCtD
Valproic Acid—Hypoaesthesia—Docetaxel—melanoma	0.000127	0.00098	CcSEcCtD
Valproic Acid—Paraesthesia—Carmustine—melanoma	0.000127	0.000977	CcSEcCtD
Valproic Acid—Pharyngitis—Docetaxel—melanoma	0.000127	0.000977	CcSEcCtD
Valproic Acid—Urinary tract disorder—Docetaxel—melanoma	0.000127	0.000972	CcSEcCtD
Valproic Acid—Dyspnoea—Carmustine—melanoma	0.000126	0.00097	CcSEcCtD
Valproic Acid—Oedema peripheral—Docetaxel—melanoma	0.000126	0.00097	CcSEcCtD
Valproic Acid—Somnolence—Carmustine—melanoma	0.000126	0.000968	CcSEcCtD
Valproic Acid—Connective tissue disorder—Docetaxel—melanoma	0.000126	0.000967	CcSEcCtD
Valproic Acid—Urethral disorder—Docetaxel—melanoma	0.000126	0.000965	CcSEcCtD
Valproic Acid—Feeling abnormal—Dactinomycin—melanoma	0.000125	0.000958	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Temozolomide—melanoma	0.000125	0.000958	CcSEcCtD
Valproic Acid—Insomnia—Temozolomide—melanoma	0.000124	0.000951	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Dactinomycin—melanoma	0.000124	0.000951	CcSEcCtD
Valproic Acid—Visual impairment—Docetaxel—melanoma	0.000123	0.000949	CcSEcCtD
Valproic Acid—Decreased appetite—Carmustine—melanoma	0.000123	0.000946	CcSEcCtD
Valproic Acid—Paraesthesia—Temozolomide—melanoma	0.000123	0.000944	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Carmustine—melanoma	0.000122	0.00094	CcSEcCtD
Valproic Acid—Dyspnoea—Temozolomide—melanoma	0.000122	0.000938	CcSEcCtD
Valproic Acid—Somnolence—Temozolomide—melanoma	0.000122	0.000935	CcSEcCtD
Valproic Acid—Erythema multiforme—Docetaxel—melanoma	0.000121	0.000931	CcSEcCtD
Valproic Acid—Pain—Carmustine—melanoma	0.000121	0.000931	CcSEcCtD
Valproic Acid—Constipation—Carmustine—melanoma	0.000121	0.000931	CcSEcCtD
Valproic Acid—Dyspepsia—Temozolomide—melanoma	0.00012	0.000926	CcSEcCtD
Valproic Acid—Eye disorder—Docetaxel—melanoma	0.00012	0.00092	CcSEcCtD
Valproic Acid—Abdominal pain—Dactinomycin—melanoma	0.00012	0.000919	CcSEcCtD
Valproic Acid—Body temperature increased—Dactinomycin—melanoma	0.00012	0.000919	CcSEcCtD
Valproic Acid—Hypersensitivity—Bleomycin—melanoma	0.00012	0.000919	CcSEcCtD
Valproic Acid—Decreased appetite—Temozolomide—melanoma	0.000119	0.000914	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Temozolomide—melanoma	0.000118	0.000908	CcSEcCtD
Valproic Acid—Fatigue—Temozolomide—melanoma	0.000118	0.000907	CcSEcCtD
Valproic Acid—Constipation—Temozolomide—melanoma	0.000117	0.000899	CcSEcCtD
Valproic Acid—Pain—Temozolomide—melanoma	0.000117	0.000899	CcSEcCtD
Valproic Acid—Feeling abnormal—Carmustine—melanoma	0.000117	0.000897	CcSEcCtD
Valproic Acid—Asthenia—Bleomycin—melanoma	0.000116	0.000895	CcSEcCtD
Valproic Acid—Angiopathy—Docetaxel—melanoma	0.000116	0.000893	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Carmustine—melanoma	0.000116	0.00089	CcSEcCtD
Valproic Acid—Immune system disorder—Docetaxel—melanoma	0.000116	0.000889	CcSEcCtD
Valproic Acid—Mediastinal disorder—Docetaxel—melanoma	0.000115	0.000887	CcSEcCtD
Valproic Acid—Chills—Docetaxel—melanoma	0.000115	0.000883	CcSEcCtD
Valproic Acid—Pruritus—Bleomycin—melanoma	0.000115	0.000882	CcSEcCtD
Valproic Acid—SLC22A5—lymph node—melanoma	0.000115	0.00519	CbGeAlD
Valproic Acid—Arrhythmia—Docetaxel—melanoma	0.000114	0.000879	CcSEcCtD
Valproic Acid—Alopecia—Docetaxel—melanoma	0.000113	0.00087	CcSEcCtD
Valproic Acid—Feeling abnormal—Temozolomide—melanoma	0.000113	0.000867	CcSEcCtD
Valproic Acid—Mental disorder—Docetaxel—melanoma	0.000112	0.000863	CcSEcCtD
Valproic Acid—Abdominal pain—Carmustine—melanoma	0.000112	0.00086	CcSEcCtD
Valproic Acid—Body temperature increased—Carmustine—melanoma	0.000112	0.00086	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Temozolomide—melanoma	0.000112	0.00086	CcSEcCtD
Valproic Acid—Malnutrition—Docetaxel—melanoma	0.000112	0.000857	CcSEcCtD
Valproic Acid—Hypersensitivity—Dactinomycin—melanoma	0.000111	0.000857	CcSEcCtD
Valproic Acid—Dysgeusia—Docetaxel—melanoma	0.000109	0.000839	CcSEcCtD
Valproic Acid—Urticaria—Temozolomide—melanoma	0.000109	0.000836	CcSEcCtD
Valproic Acid—Asthenia—Dactinomycin—melanoma	0.000109	0.000834	CcSEcCtD
Valproic Acid—Abdominal pain—Temozolomide—melanoma	0.000108	0.000831	CcSEcCtD
Valproic Acid—Body temperature increased—Temozolomide—melanoma	0.000108	0.000831	CcSEcCtD
Valproic Acid—Back pain—Docetaxel—melanoma	0.000108	0.000829	CcSEcCtD
Valproic Acid—Muscle spasms—Docetaxel—melanoma	0.000107	0.000824	CcSEcCtD
Valproic Acid—Hypersensitivity—Carmustine—melanoma	0.000104	0.000802	CcSEcCtD
Valproic Acid—Diarrhoea—Dactinomycin—melanoma	0.000104	0.000796	CcSEcCtD
Valproic Acid—Vomiting—Bleomycin—melanoma	0.000103	0.000793	CcSEcCtD
Valproic Acid—Anaemia—Docetaxel—melanoma	0.000103	0.000792	CcSEcCtD
Valproic Acid—Rash—Bleomycin—melanoma	0.000102	0.000786	CcSEcCtD
Valproic Acid—Dermatitis—Bleomycin—melanoma	0.000102	0.000785	CcSEcCtD
Valproic Acid—Asthenia—Carmustine—melanoma	0.000102	0.000781	CcSEcCtD
Valproic Acid—Hypersensitivity—Temozolomide—melanoma	0.000101	0.000775	CcSEcCtD
Valproic Acid—Leukopenia—Docetaxel—melanoma	9.98e-05	0.000767	CcSEcCtD
Valproic Acid—Palpitations—Docetaxel—melanoma	9.86e-05	0.000757	CcSEcCtD
Valproic Acid—Asthenia—Temozolomide—melanoma	9.82e-05	0.000755	CcSEcCtD
Valproic Acid—Cough—Docetaxel—melanoma	9.73e-05	0.000748	CcSEcCtD
Valproic Acid—Diarrhoea—Carmustine—melanoma	9.69e-05	0.000745	CcSEcCtD
Valproic Acid—Pruritus—Temozolomide—melanoma	9.68e-05	0.000744	CcSEcCtD
Valproic Acid—Nausea—Bleomycin—melanoma	9.64e-05	0.000741	CcSEcCtD
Valproic Acid—Hypertension—Docetaxel—melanoma	9.63e-05	0.00074	CcSEcCtD
Valproic Acid—Vomiting—Dactinomycin—melanoma	9.62e-05	0.000739	CcSEcCtD
Valproic Acid—Rash—Dactinomycin—melanoma	9.54e-05	0.000733	CcSEcCtD
Valproic Acid—Chest pain—Docetaxel—melanoma	9.5e-05	0.00073	CcSEcCtD
Valproic Acid—Arthralgia—Docetaxel—melanoma	9.5e-05	0.00073	CcSEcCtD
Valproic Acid—Myalgia—Docetaxel—melanoma	9.5e-05	0.00073	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	9.43e-05	0.000725	CcSEcCtD
Valproic Acid—Dizziness—Carmustine—melanoma	9.37e-05	0.00072	CcSEcCtD
Valproic Acid—Diarrhoea—Temozolomide—melanoma	9.37e-05	0.00072	CcSEcCtD
Valproic Acid—Dry mouth—Docetaxel—melanoma	9.29e-05	0.000714	CcSEcCtD
Valproic Acid—Confusional state—Docetaxel—melanoma	9.18e-05	0.000705	CcSEcCtD
Valproic Acid—Anaphylactic shock—Docetaxel—melanoma	9.1e-05	0.000699	CcSEcCtD
Valproic Acid—Oedema—Docetaxel—melanoma	9.1e-05	0.000699	CcSEcCtD
Valproic Acid—Dizziness—Temozolomide—melanoma	9.05e-05	0.000696	CcSEcCtD
Valproic Acid—Infection—Docetaxel—melanoma	9.04e-05	0.000695	CcSEcCtD
Valproic Acid—Vomiting—Carmustine—melanoma	9.01e-05	0.000692	CcSEcCtD
Valproic Acid—PTGS1—lymph node—melanoma	9e-05	0.00407	CbGeAlD
Valproic Acid—Nausea—Dactinomycin—melanoma	8.99e-05	0.000691	CcSEcCtD
Valproic Acid—Rash—Carmustine—melanoma	8.93e-05	0.000686	CcSEcCtD
Valproic Acid—Nervous system disorder—Docetaxel—melanoma	8.93e-05	0.000686	CcSEcCtD
Valproic Acid—Dermatitis—Carmustine—melanoma	8.92e-05	0.000686	CcSEcCtD
Valproic Acid—Thrombocytopenia—Docetaxel—melanoma	8.91e-05	0.000685	CcSEcCtD
Valproic Acid—Tachycardia—Docetaxel—melanoma	8.88e-05	0.000683	CcSEcCtD
Valproic Acid—Headache—Carmustine—melanoma	8.87e-05	0.000682	CcSEcCtD
Valproic Acid—Skin disorder—Docetaxel—melanoma	8.84e-05	0.000679	CcSEcCtD
Valproic Acid—Vomiting—Temozolomide—melanoma	8.7e-05	0.000669	CcSEcCtD
Valproic Acid—Anorexia—Docetaxel—melanoma	8.68e-05	0.000667	CcSEcCtD
Valproic Acid—Rash—Temozolomide—melanoma	8.63e-05	0.000663	CcSEcCtD
Valproic Acid—Dermatitis—Temozolomide—melanoma	8.62e-05	0.000663	CcSEcCtD
Valproic Acid—Headache—Temozolomide—melanoma	8.57e-05	0.000659	CcSEcCtD
Valproic Acid—Hypotension—Docetaxel—melanoma	8.51e-05	0.000654	CcSEcCtD
Valproic Acid—Nausea—Carmustine—melanoma	8.41e-05	0.000646	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Docetaxel—melanoma	8.29e-05	0.000637	CcSEcCtD
Valproic Acid—Insomnia—Docetaxel—melanoma	8.23e-05	0.000633	CcSEcCtD
Valproic Acid—Paraesthesia—Docetaxel—melanoma	8.17e-05	0.000628	CcSEcCtD
Valproic Acid—Nausea—Temozolomide—melanoma	8.13e-05	0.000625	CcSEcCtD
Valproic Acid—Dyspnoea—Docetaxel—melanoma	8.12e-05	0.000624	CcSEcCtD
Valproic Acid—Somnolence—Docetaxel—melanoma	8.09e-05	0.000622	CcSEcCtD
Valproic Acid—Dyspepsia—Docetaxel—melanoma	8.01e-05	0.000616	CcSEcCtD
Valproic Acid—Decreased appetite—Docetaxel—melanoma	7.91e-05	0.000608	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Docetaxel—melanoma	7.86e-05	0.000604	CcSEcCtD
Valproic Acid—Fatigue—Docetaxel—melanoma	7.85e-05	0.000603	CcSEcCtD
Valproic Acid—Pain—Docetaxel—melanoma	7.78e-05	0.000598	CcSEcCtD
Valproic Acid—Constipation—Docetaxel—melanoma	7.78e-05	0.000598	CcSEcCtD
Valproic Acid—Feeling abnormal—Docetaxel—melanoma	7.5e-05	0.000576	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Docetaxel—melanoma	7.44e-05	0.000572	CcSEcCtD
Valproic Acid—Body temperature increased—Docetaxel—melanoma	7.2e-05	0.000553	CcSEcCtD
Valproic Acid—Abdominal pain—Docetaxel—melanoma	7.2e-05	0.000553	CcSEcCtD
Valproic Acid—Hypersensitivity—Docetaxel—melanoma	6.71e-05	0.000515	CcSEcCtD
Valproic Acid—Asthenia—Docetaxel—melanoma	6.53e-05	0.000502	CcSEcCtD
Valproic Acid—Pruritus—Docetaxel—melanoma	6.44e-05	0.000495	CcSEcCtD
Valproic Acid—Diarrhoea—Docetaxel—melanoma	6.23e-05	0.000479	CcSEcCtD
Valproic Acid—Dizziness—Docetaxel—melanoma	6.02e-05	0.000463	CcSEcCtD
Valproic Acid—Vomiting—Docetaxel—melanoma	5.79e-05	0.000445	CcSEcCtD
Valproic Acid—Rash—Docetaxel—melanoma	5.74e-05	0.000441	CcSEcCtD
Valproic Acid—Dermatitis—Docetaxel—melanoma	5.73e-05	0.000441	CcSEcCtD
Valproic Acid—Headache—Docetaxel—melanoma	5.7e-05	0.000438	CcSEcCtD
Valproic Acid—Nausea—Docetaxel—melanoma	5.41e-05	0.000415	CcSEcCtD
Valproic Acid—UGT2B15—Metabolism—AKT1—melanoma	3.71e-06	2.78e-05	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—PTEN—melanoma	3.69e-06	2.77e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—ALB—melanoma	3.69e-06	2.76e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—CYP1B1—melanoma	3.68e-06	2.76e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	3.66e-06	2.74e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—VCAN—melanoma	3.65e-06	2.74e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—MYC—melanoma	3.61e-06	2.71e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—STAT3—melanoma	3.61e-06	2.7e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—NRAS—melanoma	3.6e-06	2.7e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PIK3CG—melanoma	3.6e-06	2.69e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—FGF2—melanoma	3.59e-06	2.69e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—GNA11—melanoma	3.58e-06	2.68e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PRKCA—melanoma	3.54e-06	2.65e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—ERCC2—melanoma	3.51e-06	2.63e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PHGDH—melanoma	3.51e-06	2.63e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—LUM—melanoma	3.51e-06	2.63e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—FASN—melanoma	3.5e-06	2.62e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PIK3CB—melanoma	3.48e-06	2.61e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PLA2G6—melanoma	3.48e-06	2.61e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PPARG—melanoma	3.47e-06	2.6e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	3.46e-06	2.59e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PTGS2—melanoma	3.45e-06	2.59e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—MAPK3—melanoma	3.45e-06	2.58e-05	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—PTEN—melanoma	3.45e-06	2.58e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—SLC5A5—melanoma	3.44e-06	2.58e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—HPSE—melanoma	3.44e-06	2.58e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PIK3CB—melanoma	3.39e-06	2.54e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CYP17A1—melanoma	3.38e-06	2.53e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CUBN—melanoma	3.37e-06	2.53e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MDM2—melanoma	3.36e-06	2.52e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PTGS2—melanoma	3.36e-06	2.52e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—MYC—melanoma	3.35e-06	2.51e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	3.34e-06	2.5e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	3.34e-06	2.5e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—GNAQ—melanoma	3.33e-06	2.49e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—CD44—melanoma	3.33e-06	2.49e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—ERBB2—melanoma	3.31e-06	2.48e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	3.29e-06	2.47e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—MAPK1—melanoma	3.28e-06	2.46e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—EGFR—melanoma	3.28e-06	2.46e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PIK3CB—melanoma	3.27e-06	2.45e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—SDHD—melanoma	3.26e-06	2.44e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CSPG4—melanoma	3.26e-06	2.44e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—BSG—melanoma	3.26e-06	2.44e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	3.26e-06	2.44e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	3.23e-06	2.42e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—GNA11—melanoma	3.19e-06	2.39e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—CYP1B1—melanoma	3.19e-06	2.39e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PIK3CD—melanoma	3.16e-06	2.37e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GPAM—melanoma	3.16e-06	2.37e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CXCL8—melanoma	3.14e-06	2.35e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—FASN—melanoma	3.13e-06	2.34e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—VCAN—melanoma	3.12e-06	2.34e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—ALB—melanoma	3.12e-06	2.34e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—ABCB1—melanoma	3.1e-06	2.32e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—KRAS—melanoma	3.1e-06	2.32e-05	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—AKT1—melanoma	3.09e-06	2.32e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CYP17A1—melanoma	3.08e-06	2.31e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—SLC5A5—melanoma	3.07e-06	2.3e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.07e-06	2.3e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CDKN1B—melanoma	3.07e-06	2.3e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	3.04e-06	2.28e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—ABCB1—melanoma	3.03e-06	2.27e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PTEN—melanoma	3.01e-06	2.26e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CASP3—melanoma	3.01e-06	2.25e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—IL2—melanoma	3e-06	2.25e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	3e-06	2.25e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—GNAQ—melanoma	2.97e-06	2.23e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CD44—melanoma	2.97e-06	2.23e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.96e-06	2.22e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PIK3CG—melanoma	2.93e-06	2.2e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PTEN—melanoma	2.93e-06	2.2e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CCND1—melanoma	2.93e-06	2.19e-05	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—PIK3CA—melanoma	2.92e-06	2.19e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—GNA11—melanoma	2.91e-06	2.18e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.91e-06	2.18e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CTNNB1—melanoma	2.9e-06	2.17e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.88e-06	2.16e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PRKCA—melanoma	2.85e-06	2.14e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.85e-06	2.14e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—FASN—melanoma	2.85e-06	2.14e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CYP1B1—melanoma	2.85e-06	2.13e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—PIK3CA—melanoma	2.85e-06	2.13e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MMP9—melanoma	2.84e-06	2.13e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CDKN1A—melanoma	2.83e-06	2.12e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—ERCC2—melanoma	2.83e-06	2.12e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PPARG—melanoma	2.83e-06	2.12e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PTEN—melanoma	2.83e-06	2.12e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.81e-06	2.11e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—NFKB1—melanoma	2.81e-06	2.11e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—SLC5A5—melanoma	2.8e-06	2.1e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PRKCA—melanoma	2.79e-06	2.09e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PIK3CG—melanoma	2.77e-06	2.08e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—ERCC2—melanoma	2.77e-06	2.07e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PIK3CB—melanoma	2.75e-06	2.06e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PTGS2—melanoma	2.73e-06	2.05e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—GNAQ—melanoma	2.71e-06	2.03e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CD44—melanoma	2.71e-06	2.03e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PLA2G6—melanoma	2.68e-06	2.01e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PPARG—melanoma	2.67e-06	2e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.65e-06	1.99e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CYP17A1—melanoma	2.63e-06	1.97e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—HRAS—melanoma	2.63e-06	1.97e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.63e-06	1.97e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—ABCB1—melanoma	2.63e-06	1.97e-05	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—PIK3CA—melanoma	2.61e-06	1.95e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.6e-06	1.95e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CYP1B1—melanoma	2.6e-06	1.95e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PIK3CD—melanoma	2.58e-06	1.93e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	2.57e-06	1.92e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—VEGFA—melanoma	2.55e-06	1.91e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—ALB—melanoma	2.54e-06	1.91e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—STAT3—melanoma	2.53e-06	1.89e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—NRAS—melanoma	2.52e-06	1.89e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—IL6—melanoma	2.52e-06	1.89e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.51e-06	1.88e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—AKT1—melanoma	2.5e-06	1.88e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—GNA11—melanoma	2.49e-06	1.86e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PIK3CD—melanoma	2.44e-06	1.83e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—FASN—melanoma	2.44e-06	1.82e-05	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—PIK3CA—melanoma	2.43e-06	1.82e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PRKCA—melanoma	2.42e-06	1.81e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MAPK3—melanoma	2.41e-06	1.81e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—VCAN—melanoma	2.41e-06	1.81e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—ALB—melanoma	2.41e-06	1.8e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—ERCC2—melanoma	2.4e-06	1.8e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—SLC5A5—melanoma	2.4e-06	1.8e-05	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—AKT1—melanoma	2.39e-06	1.79e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PTEN—melanoma	2.38e-06	1.78e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MYC—melanoma	2.35e-06	1.76e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—ABCB1—melanoma	2.34e-06	1.76e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—AKT1—melanoma	2.32e-06	1.74e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CD44—melanoma	2.31e-06	1.73e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—GNAQ—melanoma	2.31e-06	1.73e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MAPK1—melanoma	2.3e-06	1.72e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—EGFR—melanoma	2.3e-06	1.72e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.29e-06	1.72e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.27e-06	1.7e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PIK3CB—melanoma	2.25e-06	1.68e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.24e-06	1.68e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PIK3CG—melanoma	2.24e-06	1.68e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PTGS2—melanoma	2.23e-06	1.67e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CYP1B1—melanoma	2.22e-06	1.66e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PIK3CG—melanoma	2.19e-06	1.64e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—KRAS—melanoma	2.17e-06	1.63e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PPARG—melanoma	2.16e-06	1.62e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PRKCA—melanoma	2.16e-06	1.62e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—ERCC2—melanoma	2.14e-06	1.6e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—ABCB1—melanoma	2.14e-06	1.6e-05	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—AKT1—melanoma	2.13e-06	1.6e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PIK3CA—melanoma	2.12e-06	1.59e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PIK3CB—melanoma	2.12e-06	1.59e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PPARG—melanoma	2.11e-06	1.58e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PTGS2—melanoma	2.1e-06	1.58e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PIK3CA—melanoma	2.07e-06	1.55e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CYP17A1—melanoma	2.03e-06	1.52e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PIK3CA—melanoma	1.99e-06	1.49e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.99e-06	1.49e-05	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—AKT1—melanoma	1.99e-06	1.49e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PRKCA—melanoma	1.97e-06	1.47e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PIK3CD—melanoma	1.97e-06	1.47e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.96e-06	1.47e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—ERCC2—melanoma	1.95e-06	1.46e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PTEN—melanoma	1.94e-06	1.45e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—ALB—melanoma	1.94e-06	1.45e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TP53—melanoma	1.93e-06	1.44e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PIK3CD—melanoma	1.92e-06	1.44e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GNA11—melanoma	1.92e-06	1.44e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—ALB—melanoma	1.9e-06	1.42e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PIK3CG—melanoma	1.89e-06	1.42e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—FASN—melanoma	1.88e-06	1.41e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—SLC5A5—melanoma	1.85e-06	1.39e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—HRAS—melanoma	1.84e-06	1.38e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PTEN—melanoma	1.83e-06	1.38e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PPARG—melanoma	1.83e-06	1.37e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ABCB1—melanoma	1.83e-06	1.37e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GNAQ—melanoma	1.79e-06	1.34e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CD44—melanoma	1.79e-06	1.34e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.77e-06	1.33e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—IL6—melanoma	1.76e-06	1.32e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—AKT1—melanoma	1.74e-06	1.3e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PIK3CB—melanoma	1.71e-06	1.28e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CYP1B1—melanoma	1.71e-06	1.28e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PTGS2—melanoma	1.7e-06	1.27e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PIK3CG—melanoma	1.69e-06	1.27e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—AKT1—melanoma	1.69e-06	1.27e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PRKCA—melanoma	1.68e-06	1.26e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PIK3CA—melanoma	1.68e-06	1.26e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PIK3CB—melanoma	1.67e-06	1.26e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ERCC2—melanoma	1.67e-06	1.25e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PIK3CD—melanoma	1.66e-06	1.25e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PTGS2—melanoma	1.66e-06	1.24e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—ALB—melanoma	1.64e-06	1.23e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PPARG—melanoma	1.63e-06	1.22e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—AKT1—melanoma	1.63e-06	1.22e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.62e-06	1.21e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PIK3CG—melanoma	1.54e-06	1.15e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PPARG—melanoma	1.49e-06	1.11e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PIK3CD—melanoma	1.49e-06	1.11e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PTEN—melanoma	1.48e-06	1.11e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—ALB—melanoma	1.47e-06	1.1e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PIK3CB—melanoma	1.45e-06	1.09e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PTEN—melanoma	1.45e-06	1.08e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PTGS2—melanoma	1.44e-06	1.08e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ABCB1—melanoma	1.41e-06	1.06e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.38e-06	1.03e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—AKT1—melanoma	1.37e-06	1.03e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PIK3CA—melanoma	1.37e-06	1.03e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PIK3CD—melanoma	1.35e-06	1.02e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—ALB—melanoma	1.34e-06	1e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PIK3CG—melanoma	1.32e-06	9.87e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PRKCA—melanoma	1.3e-06	9.72e-06	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PIK3CB—melanoma	1.29e-06	9.7e-06	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PIK3CA—melanoma	1.29e-06	9.7e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ERCC2—melanoma	1.29e-06	9.64e-06	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PTGS2—melanoma	1.28e-06	9.61e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PPARG—melanoma	1.27e-06	9.52e-06	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PTEN—melanoma	1.25e-06	9.39e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PIK3CB—melanoma	1.18e-06	8.85e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PTGS2—melanoma	1.17e-06	8.77e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PIK3CD—melanoma	1.16e-06	8.67e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ALB—melanoma	1.14e-06	8.56e-06	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PTEN—melanoma	1.12e-06	8.38e-06	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—AKT1—melanoma	1.12e-06	8.38e-06	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—AKT1—melanoma	1.06e-06	7.93e-06	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PIK3CA—melanoma	1.04e-06	7.83e-06	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PIK3CA—melanoma	1.02e-06	7.65e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PTEN—melanoma	1.02e-06	7.65e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PIK3CG—melanoma	1.02e-06	7.61e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PIK3CB—melanoma	1.01e-06	7.56e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PTGS2—melanoma	1e-06	7.49e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PPARG—melanoma	9.81e-07	7.35e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PIK3CD—melanoma	8.93e-07	6.69e-06	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PIK3CA—melanoma	8.84e-07	6.63e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ALB—melanoma	8.82e-07	6.61e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PTEN—melanoma	8.72e-07	6.53e-06	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—AKT1—melanoma	8.53e-07	6.39e-06	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—AKT1—melanoma	8.34e-07	6.25e-06	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PIK3CA—melanoma	7.89e-07	5.91e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PIK3CB—melanoma	7.79e-07	5.83e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PTGS2—melanoma	7.71e-07	5.78e-06	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—AKT1—melanoma	7.22e-07	5.41e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PIK3CA—melanoma	7.2e-07	5.39e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PTEN—melanoma	6.73e-07	5.04e-06	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—AKT1—melanoma	6.45e-07	4.83e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PIK3CA—melanoma	6.15e-07	4.61e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—AKT1—melanoma	5.88e-07	4.41e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—AKT1—melanoma	5.02e-07	3.77e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PIK3CA—melanoma	4.75e-07	3.56e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—AKT1—melanoma	3.88e-07	2.91e-06	CbGpPWpGaD
